Protara Therapeutics, Inc. (TARA) has a market capitalization of $197.96M and trades at $5.13. The 52-week range is 2.77-7.82.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.8, Earnings Per Share (EPS) of $-1.34.
The stock has a beta of 1.50, operates in the Healthcare sector.
